| 34224165 |
Total |
|
View |
| 34120255 |
Patients without complications |
|
View |
| 30929223 |
|
|
View |
| 30891454 |
group 1 |
|
View |
| 30891454 |
group 2 |
|
View |
| 30801887 |
total |
|
View |
| 30798475 |
Group 1 |
|
View |
| 30798475 |
Group 2 |
|
View |
| 30691961 |
|
|
View |
| 30681267 |
total |
|
View |
| 30681267 |
ORP |
|
View |
| 30681267 |
LRP |
|
View |
| 33951669 |
Group 1: SL |
|
View |
| 30681267 |
RARP |
|
View |
| 30548814 |
|
|
View |
| 30548814 |
|
|
View |
| 30519744 |
Total |
|
View |
| 30519744 |
negative surgical margins |
|
View |
| 30519744 |
unifocal positive surgical margin |
|
View |
| 30519744 |
multifocal positive surgical margins |
|
View |
| 30426256 |
TR-RALP |
|
View |
| 30426256 |
RS-RALP |
|
View |
| 30375062 |
US-guided PFMT |
|
View |
| 33951669 |
Group 2: no SL |
|
View |
| 30375062 |
Verbal-PFMT |
|
View |
| 30279989 |
total |
|
View |
| 30276864 |
total |
|
View |
| 32005115 |
Moderate/poor work ability |
|
View |
| 32005115 |
High work ability |
|
View |
| 32005115 |
Total sample |
|
View |
| 31984644 |
|
|
View |
| 28823768 |
RARP |
|
View |
| 28823768 |
PGA |
|
View |
| 24314031 |
|
|
View |
| 33879394 |
Group 1 |
|
View |
| 19888970 |
|
|
View |
| 29633374 |
Group 1 |
|
View |
| 29633374 |
Group 2 |
|
View |
| 29195014 |
Overall |
|
View |
| 29195014 |
ORP |
|
View |
| 29195014 |
RARP |
|
View |
| 29086019 |
Total |
|
View |
| 28718690 |
|
|
View |
| 28687029 |
total |
|
View |
| 28687029 |
With metabolic syndrome |
|
View |
| 33879394 |
Group 2 |
|
View |
| 28687029 |
Without metabolic syndrome |
|
View |
| 28677091 |
Group A |
|
View |
| 28677091 |
Group B |
|
View |
| 28483330 |
Anterior RARP approach |
|
View |
| 28483330 |
Posterior RARP approach |
|
View |
| 28462944 |
total |
|
View |
| 28130703 |
LRP |
|
View |
| 28130703 |
RARP |
|
View |
| 28081352 |
Total |
|
View |
| 28081352 |
Traction group |
|
View |
| 33663015 |
Non-PR |
|
View |
| 28081352 |
Nontraction Group |
|
View |
| 21489117 |
total |
|
View |
| 28867561 |
|
|
View |
| 28867561 |
|
|
View |
| 28867561 |
|
|
View |
| 34462255 |
all |
|
View |
| 32588704 |
No lymphocele group |
|
View |
| 32588704 |
Lymphocele group |
|
View |
| 32327264 |
all |
|
View |
| 32192919 |
Learning curve surgeons |
|
View |
| 33663015 |
PR |
|
View |
| 32192919 |
Expert surgeons |
|
View |
| 31980875 |
No hospital readmission |
|
View |
| 31980875 |
Hospital readmission |
|
View |
| 31959548 |
all |
|
View |
| 31899555 |
all |
|
View |
| 31067558 |
Lymph node invasion-absent |
|
View |
| 31067558 |
Lymph node invasion-present |
|
View |
| 31067558 |
Lymph node invasion with Marcille’s Triangle involvement-absent |
|
View |
| 31067558 |
Lymph node invasion with Marcille’s Triangle involvement-present |
|
View |
| 30398382 |
Drain placed in the pelvic cavity=yes |
|
View |
| 33551295 |
Total |
|
View |
| 30398382 |
Drain placed in the pelvic cavity=no |
|
View |
| 29767326 |
ePLND without ICG |
|
View |
| 29767326 |
ePLND after transrectal injection of ICG |
|
View |
| 29737495 |
Overall |
|
View |
| 29737495 |
Grade (0-2) |
|
View |
| 29737495 |
Grade 3 (3a-3b) |
|
View |
| 29472629 |
Overall |
|
View |
| 29472629 |
LNI risk <5% |
|
View |
| 29472629 |
LNI risk ≥5% |
|
View |
| 29427005 |
Overall |
|
View |
| 33551295 |
Urethral fixation |
|
View |
| 29427005 |
RRP |
|
View |
| 29427005 |
RARP/LARP |
|
View |
| 29230586 |
Total |
|
View |
| 29230586 |
LPLND |
|
View |
| 29230586 |
EPLND |
|
View |
| 29072565 |
Q1 |
|
View |
| 29072565 |
Q2 |
|
View |
| 29072565 |
Q3 |
|
View |
| 29072565 |
Q4 |
|
View |
| 29072565 |
Overall |
|
View |
| 33551295 |
Standard vesicourethral anastomosis |
|
View |
| 28905289 |
None |
|
View |
| 28905289 |
Adjuvant |
|
View |
| 28905289 |
Salvage |
|
View |
| 28747519 |
Overall |
|
View |
| 28747519 |
ePLND |
|
View |
| 28747519 |
ePLND+SNB |
|
View |
| 28645325 |
Intermediate-risk |
|
View |
| 28645325 |
High-risk |
|
View |
| 28281741 |
All patients |
|
View |
| 28281741 |
SLND |
|
View |
| 34224165 |
Non‐BCR |
|
View |
| 33495942 |
Pre-intervention |
|
View |
| 28281741 |
ELND |
|
View |
| 27981731 |
Total |
|
View |
| 27878050 |
Overall |
|
View |
| 27878050 |
ORP |
|
View |
| 27878050 |
RARP |
|
View |
| 30003407 |
Inpatient RARP |
|
View |
| 30003407 |
Outpatient RARP |
|
View |
| 27544575 |
Total cohort |
|
View |
| 27544575 |
Group A |
|
View |
| 27544575 |
Group B |
|
View |
| 33495942 |
Post-intervention |
|
View |
| 26800257 |
Lymphocele (+) |
|
View |
| 26800257 |
Lymphocele (-) |
|
View |
| 26768422 |
SN + ePLND |
|
View |
| 26768422 |
SN + ePLND, customized settings |
|
View |
| 26531111 |
total |
|
View |
| 26531111 |
Prolonged OR |
|
View |
| 26531111 |
Not prolonged |
|
View |
| 26502293 |
Total |
|
View |
| 26502293 |
A mentor |
|
View |
| 26502293 |
New surgeons with a mentor |
|
View |
| 25216924 |
|
|
View |
| 25899767 |
Overall |
|
View |
| 25899767 |
Lymph nodes present in APFP |
|
View |
| 25899767 |
Lymph nodes absent in APFP |
|
View |
| 25443913 |
Overall |
|
View |
| 25443913 |
Group 1 |
|
View |
| 25443913 |
Group 2 |
|
View |
| 25443913 |
Group 3 |
|
View |
| 25443913 |
Group 4 |
|
View |
| 25325024 |
High-risk |
|
View |
| 25325024 |
Very high-risk |
|
View |
| 27637685 |
|
|
View |
| 25038184 |
All |
|
View |
| 25038184 |
LN (-) |
|
View |
| 25038184 |
LN(+) |
|
View |
| 24964296 |
All patients |
|
View |
| 24964296 |
MI-PLND |
|
View |
| 24964296 |
O-PLND |
|
View |
| 24006951 |
Overall |
|
View |
| 24006951 |
LN- |
|
View |
| 24006951 |
LN+ |
|
View |
| 23521086 |
Total |
|
View |
| 27628466 |
|
|
View |
| 23521086 |
group 1 |
|
View |
| 23521086 |
group 2 |
|
View |
| 23356436 |
sLND |
|
View |
| 23356436 |
eLND |
|
View |
| 33997823 |
Salvage RARP |
|
View |
| 33997823 |
RARP |
|
View |
| 22967037 |
Standard PLND |
|
View |
| 22967037 |
Extended PLND |
|
View |
| 33912513 |
Total |
|
View |
| 33912513 |
Open |
|
View |
| 33267679 |
|
|
View |
| 33912513 |
Robot-Assisted |
|
View |
| 22834963 |
LRP |
|
View |
| 22834963 |
RALP |
|
View |
| 30790014 |
Overall |
|
View |
| 28373480 |
Overall |
|
View |
| 27751731 |
Group 1 |
|
View |
| 27751731 |
Group 2 |
|
View |
| 27751731 |
Group 3 |
|
View |
| 22556136 |
Group 1 |
|
View |
| 22556136 |
Group 2 |
|
View |
| 33185707 |
Overall |
|
View |
| 31555579 |
Open sLND |
|
View |
| 31555579 |
Robotic sLND |
|
View |
| 27600589 |
Overall |
|
View |
| 21851536 |
Lymph nodes present in anterior lymphofatty tissue ALFT |
|
View |
| 21851536 |
Lymph nodes absent in lymphofatty tissue ALFT |
|
View |
| 33426579 |
LigaSure |
|
View |
| 33426579 |
Hem-o-lok |
|
View |
| 27628630 |
RARP |
|
View |
| 27628630 |
RRR |
|
View |
| 27638369 |
group 1 |
|
View |
| 33185707 |
Nerve sparing (+) |
|
View |
| 27638369 |
group 2 |
|
View |
| 19515403 |
R-PLND |
|
View |
| 19515403 |
No PLND |
|
View |
| 19245295 |
First quarter |
|
View |
| 19245295 |
Second quarter |
|
View |
| 19245295 |
Third quarter |
|
View |
| 19245295 |
Fourth quarter |
|
View |
| 19245295 |
Total |
|
View |
| 19196060 |
Quarter 1 |
|
View |
| 19196060 |
Quarter 2 |
|
View |
| 33185707 |
Nerve sparing (−) |
|
View |
| 19196060 |
Quarter 3 |
|
View |
| 19196060 |
Quarter 4 |
|
View |
| 18480623 |
Group A |
|
View |
| 18480623 |
Group B |
|
View |
| 18480623 |
Group C |
|
View |
| 35083274 |
Dry patients |
|
View |
| 35083274 |
wet patients |
|
View |
| 35083072 |
Group A |
|
View |
| 35083072 |
Group B |
|
View |
| 34562303 |
total |
|
View |
| 33112984 |
TAR group |
|
View |
| 34384621 |
Athermal |
|
View |
| 34384621 |
Cautery |
|
View |
| 34222808 |
total |
|
View |
| 33554284 |
Standard |
|
View |
| 33554284 |
Si |
|
View |
| 33554284 |
Si |
|
View |
| 33554284 |
Xi |
|
View |
| 33554284 |
Xi |
|
View |
| 33554284 |
SP |
|
View |
| 33474847 |
total |
|
View |
| 34224165 |
BCR |
|
View |
| 33112984 |
TAR+TZ sling group |
|
View |
| 33474847 |
Non-ED |
|
View |
| 33474847 |
ED |
|
View |
| 33357994 |
SP |
|
View |
| 33357994 |
Xi |
|
View |
| 33357990 |
MP-RARP |
|
View |
| 33357990 |
SP-RPP |
|
View |
| 33160915 |
All |
|
View |
| 33160915 |
MP-RARP |
|
View |
| 33160915 |
SP-EPP |
|
View |
| 32931133 |
NS group |
|
View |
| 33064316 |
Continence group (n = 48) |
|
View |
| 32931133 |
Non‐NS group |
|
View |
| 32896583 |
SP-RALRP (Pooled) |
|
View |
| 32896583 |
Standard RALRP |
|
View |
| 32631777 |
Multi-port |
|
View |
| 32631777 |
Single-port |
|
View |
| 32521115 |
Cut & Suture |
|
View |
| 32521115 |
Stapler |
|
View |
| 32521115 |
Suspension |
|
View |
| 34847882 |
Xi |
|
View |
| 34847882 |
Si |
|
View |
| 33064316 |
Incontinence group (n = 80 |
|
View |
| 32402143 |
all |
|
View |
| 32158968 |
all |
|
View |
| 32158316 |
Control group |
|
View |
| 32158316 |
Reconstructive group |
|
View |
| 33275823 |
Sexual intercourse |
|
View |
| 33275823 |
Sexual activity except sexual intercourse |
|
View |
| 33275823 |
No sexual activity |
|
View |
| 31929596 |
group 1 |
|
View |
| 31929596 |
group 2 |
|
View |
| 31586543 |
Bladder neck reconstruction |
|
View |
| 26881411 |
|
|
View |
| 31586543 |
Bladder neck sparing |
|
View |
| 31579411 |
NS cohort |
|
View |
| 31579411 |
non-NS cohort |
|
View |
| 31386793 |
all |
|
View |
| 31301693 |
SP-RALP |
|
View |
| 31257704 |
SP-RARP |
|
View |
| 31010600 |
SP-RARP |
|
View |
| 30697080 |
ORP |
|
View |
| 30697080 |
LRP |
|
View |
| 30697080 |
RARP |
|
View |
| 32861619 |
Frail |
|
View |
| 30727795 |
RRP |
|
View |
| 30727795 |
RALP |
|
View |
| 30021425 |
eRARP |
|
View |
| 30006861 |
s-DVC group |
|
View |
| 30006861 |
d-DVC group |
|
View |
| 29371819 |
IIEF‐Q1 score (≥2) |
|
View |
| 29371819 |
IIEF‐Q1 score (0 or 1) |
|
View |
| 29061068 |
2-layered |
|
View |
| 29061068 |
3-layered |
|
View |
| 28122393 |
No NS nerve sparing |
|
View |
| 32861619 |
Nonfrail |
|
View |
| 28122393 |
NS nerve sparing |
|
View |
| 27743849 |
Intussusception |
|
View |
| 27743849 |
Nonintussusception |
|
View |
| 27503582 |
Controls |
|
View |
| 27503582 |
PUS |
|
View |
| 26578444 |
Day 2-Postoperative catheter removal |
|
View |
| 26578444 |
Day 6-Postoperative catheter removal |
|
View |
| 26397733 |
Kim’s stitch group |
|
View |
| 26397733 |
Control group |
|
View |
| 24739066 |
Group A PRAS alone |
|
View |
| 25422166 |
Prior surgery |
|
View |
| 24739066 |
Group B MULP + PRAS |
|
View |
| 24739066 |
Group C MULP alone |
|
View |
| 24693529 |
BNC |
|
View |
| 24693529 |
No BNC |
|
View |
| 24612011 |
Matched conventional RALP |
|
View |
| 24612011 |
Retzius-sparing RALP |
|
View |
| 24166291 |
CINPT |
|
View |
| 24166291 |
No CINPT |
|
View |
| 33550690 |
AXR-TEP |
|
View |
| 33550690 |
IP-TEP |
|
View |
| 25422166 |
Non-prior surgery |
|
View |
| 32775266 |
TP-RALP |
|
View |
| 32775266 |
EP-RALP |
|
View |
| 32715451 |
EP-RALP |
|
View |
| 32715451 |
TP-RALP |
|
View |
| 30680229 |
TPRP |
|
View |
| 30680229 |
RARP |
|
View |
| 30680229 |
ERP |
|
View |
| 29225060 |
Anterior RARP |
|
View |
| 29225060 |
Posterior RARP |
|
View |
| 21992461 |
retro-apical group |
|
View |
| 27388671 |
|
|
View |
| 21992461 |
anterior-apical group |
|
View |
| 22998904 |
Bladder Neck Sparing |
|
View |
| 22998904 |
Bladder Neck Nonsparing |
|
View |
| 22738925 |
INS: intrafascial |
|
View |
| 22738925 |
Non-INS: inter-/extrafascial, no nerve-sparing |
|
View |
| 21830910 |
all |
|
View |
| 21620561 |
Without countertraction |
|
View |
| 21620561 |
With countertraction |
|
View |
| 20825759 |
RALP+Pubovesical Complex-Sparing Technique |
|
View |
| 20863611 |
Division and selective suturing of dorsal vein complex |
|
View |
| 32696130 |
Whole Cohort |
|
View |
| 20863611 |
Non-selective suturing followed by division of dorsal vein complex |
|
View |
| 20818988 |
Study group |
|
View |
| 20818988 |
Control group |
|
View |
| 20801579 |
Without reconstruction |
|
View |
| 20801579 |
Posterior reconstruction |
|
View |
| 20626271 |
all |
|
View |
| 20362386 |
No MFRR |
|
View |
| 20362386 |
MFRR |
|
View |
| 23675138 |
all |
|
View |
| 19195692 |
No ED |
|
View |
| 21226623 |
Total |
|
View |
| 32696130 |
BCR-Negative group |
|
View |
| 19195692 |
ED |
|
View |
| 19178174 |
Technique 1 |
|
View |
| 19178174 |
Technique 2 |
|
View |
| 19171418 |
Continent men |
|
View |
| 19171418 |
Incontinent men |
|
View |
| 18419333 |
Bilateral SNG |
|
View |
| 18419333 |
Unilateral SNG |
|
View |
| 18419333 |
Unilateral NS, no SNG |
|
View |
| 18047953 |
Group 1 |
|
View |
| 18047953 |
Group 2 |
|
View |
| 32696130 |
BCR-Positive group |
|
View |
| 30054696 |
DROP-IN probe used in robot-assisted radioguided surgery |
|
View |
| 34268880 |
total |
|
View |
| 30143383 |
|
|
View |
| 30143383 |
|
|
View |
| 27933389 |
RRPE |
|
View |
| 27933389 |
ORPE |
|
View |
| 27933389 |
LRPE |
|
View |
| 27157376 |
10 th Percentile of Costs |
|
View |
| 27157376 |
90 th Percentile of Costs |
|
View |
| 22967039 |
Patients undergoing RALRP |
|
View |
| 32639601 |
ERAS−/PreHab− |
|
View |
| 22967039 |
Patients undergoing RRP |
|
View |
| 30413390 |
Group 1 (POD 3) |
|
View |
| 30413390 |
Group 2 (POD 5) |
|
View |
| 28153509 |
Very
Low |
|
View |
| 28153509 |
High |
|
View |
| 21457071 |
Premodifications |
|
View |
| 21457071 |
Postmodifications |
|
View |
| 28419326 |
<10 km |
|
View |
| 28419326 |
10-29 km |
|
View |
| 28419326 |
>30 km |
|
View |
| 32639601 |
ERAS+/PreHab− |
|
View |
| 33359493 |
High (Score>15) |
|
View |
| 33359493 |
Low (Score ≤15) |
|
View |
| 28710845 |
total |
|
View |
| 29789672 |
CS group |
|
View |
| 29789672 |
FTS group |
|
View |
| 31187653 |
Study group |
|
View |
| 31187653 |
Control group |
|
View |
| 34138904 |
total |
|
View |
| 34692589 |
Group I |
|
View |
| 34692589 |
Group II |
|
View |
| 32639601 |
ERAS+/PreHab+ |
|
View |
| 21605514 |
total |
|
View |
| 31228477 |
R |
|
View |
| 31228477 |
NR |
|
View |
| 27841089 |
Patients taking tadalafil |
|
View |
| 27841089 |
Patients not taking tadalafil |
|
View |
| 30253389 |
Very low volume |
|
View |
| 30253389 |
Low volume |
|
View |
| 30253389 |
Intermediate volume |
|
View |
| 30253389 |
High volume |
|
View |
| 32328779 |
Pentafecta not achieved |
|
View |
| 32591157 |
Group 1: iPSA level <5.0 |
|
View |
| 32328779 |
Pentafecta achieved |
|
View |
| 28853623 |
Readmission |
|
View |
| 28853623 |
No readmission |
|
View |
| 27083922 |
LOS = 1 |
|
View |
| 27083922 |
LOS>1 |
|
View |
| 30777723 |
4-6 d |
|
View |
| 30777723 |
7d |
|
View |
| 30777723 |
8-11d |
|
View |
| 30777723 |
1 d |
|
View |
| 30777723 |
2-3 d |
|
View |
| 32591157 |
Group 2: iPSA level 5.0-9.9 |
|
View |
| 30777723 |
4-7 d |
|
View |
| 30777723 |
>7 d |
|
View |
| 35083069 |
Total |
|
View |
| 35083069 |
<120 min |
|
View |
| 35083069 |
120-180 min |
|
View |
| 35083069 |
181-240 min |
|
View |
| 35083069 |
>240 min |
|
View |
| 35083069 |
<2 g/dl |
|
View |
| 35083069 |
2-4 g/dl |
|
View |
| 35083069 |
>4 g/dl |
|
View |
| 32591157 |
Group 3: iPSA level ≥ 10 |
|
View |
| 34876905 |
Anterior approach |
|
View |
| 34876905 |
Transvesical approach |
|
View |
| 34876905 |
Posterior approach |
|
View |
| 34423666 |
Control group |
|
View |
| 34423666 |
ERAS group |
|
View |
| 33941161 |
Minor |
|
View |
| 33941161 |
Major |
|
View |
| 33941161 |
Minor + major |
|
View |
| 33941161 |
Leakage (−) |
|
View |
| 33879996 |
Positive |
|
View |
| 32537666 |
Age>70 |
|
View |
| 33879996 |
Negative |
|
View |
| 29201511 |
1st case |
|
View |
| 29201511 |
2nd case |
|
View |
| 29201511 |
3rd case |
|
View |
| 29201511 |
4th case |
|
View |
| 29201511 |
5th case |
|
View |
| 29201511 |
6th case |
|
View |
| 29201511 |
7th case |
|
View |
| 29201511 |
8th case |
|
View |
| 29201511 |
9th case |
|
View |
| 32537666 |
Age≤70 |
|
View |
| 29201511 |
10th case |
|
View |
| 29201511 |
11th case |
|
View |
| 29201511 |
12th case |
|
View |
| 29201511 |
13th case |
|
View |
| 29201511 |
14th case |
|
View |
| 29201511 |
15th case |
|
View |
| 33623874 |
Group A |
|
View |
| 33623874 |
Group B |
|
View |
| 33508874 |
Continence at 3 months |
|
View |
| 33508874 |
Incontinence at 3 months |
|
View |
| 34155724 |
Group 1 |
|
View |
| 32461073 |
Overall |
|
View |
| 33508874 |
Continence at 12 months |
|
View |
| 33508874 |
Incontinence at 12 months |
|
View |
| 32944518 |
Early |
|
View |
| 32944518 |
Delayed |
|
View |
| 32944518 |
Non-LIESWT |
|
View |
| 28054309 |
Era 2005-2009 |
|
View |
| 28054309 |
Era 2010-2014 |
|
View |
| 22398201 |
Total |
|
View |
| 32754332 |
Total |
|
View |
| 32754332 |
ORP |
|
View |
| 32461073 |
Whole-gland treatment (Total) |
|
View |
| 32754332 |
RARP |
|
View |
| 32564173 |
RARP |
|
View |
| 32564173 |
ORP |
|
View |
| 32449896 |
Total study sample |
|
View |
| 32449896 |
Peritoneal flap |
|
View |
| 32449896 |
Control group |
|
View |
| 32257810 |
Group 1 |
|
View |
| 32257810 |
Group 2 |
|
View |
| 32257810 |
Group 3 |
|
View |
| 32257810 |
Group 4 |
|
View |
| 32461073 |
Focal treatment (Total) |
|
View |
| 32257810 |
Group 5 |
|
View |
| 31579118 |
RARP |
|
View |
| 34917689 |
Total |
|
View |
| 31384606 |
Total |
|
View |
| 31355454 |
RARP |
|
View |
| 31355454 |
RRP |
|
View |
| 30891454 |
Group 1 |
|
View |
| 30891454 |
Group 2 |
|
View |
| 30740014 |
Valveless Trocar Group |
|
View |
| 30740014 |
Control Group |
|
View |
| 32451781 |
|
|
View |
| 30212952 |
Total |
|
View |
| 34970314 |
surgery1 |
|
View |
| 34970314 |
surgery2 |
|
View |
| 30183609 |
surgery1 |
|
View |
| 30183609 |
surgery2 |
|
View |
| 28988599 |
very-low-risk |
|
View |
| 28988599 |
low-risk |
|
View |
| 34631541 |
LRP |
|
View |
| 34631541 |
RARP |
|
View |
| 34432012 |
ORP |
|
View |
| 32378083 |
|
|
View |
| 34432012 |
LRP |
|
View |
| 34432012 |
RARP |
|
View |
| 34337458 |
|
|
View |
| 33437271 |
ORP |
|
View |
| 33437271 |
RARP |
|
View |
| 33240927 |
Overall |
|
View |
| 33240927 |
≤40cc |
|
View |
| 33240927 |
>40cc |
|
View |
| 33240927 |
Normal weight |
|
View |
| 33240927 |
Overweight |
|
View |
| 32333202 |
Total cohort |
|
View |
| 33240927 |
Obese |
|
View |
| 33029430 |
LRP |
|
View |
| 33029430 |
RALRP |
|
View |
| 32748620 |
ORP |
|
View |
| 32748620 |
RS-RSRP |
|
View |
| 32648416 |
RARP |
|
View |
| 32648416 |
ORP |
|
View |
| 31833722 |
Total |
|
View |
| 31833722 |
No hospital readmission |
|
View |
| 31833722 |
Hospital readmission |
|
View |
| 32333202 |
pN1 patients |
|
View |
| 31807424 |
ORP |
|
View |
| 31807424 |
LRP |
|
View |
| 31807424 |
RALRP |
|
View |
| 31603415 |
RARP |
|
View |
| 31603415 |
LRP |
|
View |
| 31576266 |
Group 1 (1-45) |
|
View |
| 31576266 |
Group 2 (46-91) |
|
View |
| 30937294 |
RARP |
|
View |
| 30937294 |
LRP |
|
View |
| 30937294 |
RRP |
|
View |
| 28253500 |
Total cohort |
|
View |
| 30901171 |
Tp-RLRP |
|
View |
| 30901171 |
Ep-RLRP |
|
View |
| 30901171 |
Ep-LRP |
|
View |
| 29757580 |
RALP |
|
View |
| 29757580 |
RRP |
|
View |
| 29463975 |
RRP |
|
View |
| 29463975 |
LRP |
|
View |
| 29463975 |
RARP |
|
View |
| 29264170 |
RARP |
|
View |
| 29264170 |
RRP |
|
View |
| 27989916 |
Overall |
|
View |
| 26019939 |
RRP |
|
View |
| 26019939 |
RPP |
|
View |
| 26019939 |
RRP |
|
View |
| 26019939 |
RPP |
|
View |
| 25790013 |
Group 1(ROBOTIC) |
|
View |
| 25790013 |
Group 2 (OPEN) |
|
View |
| 25770484 |
ORP |
|
View |
| 25770484 |
RARP |
|
View |
| 25183452 |
Open |
|
View |
| 25183452 |
Laparoscopic |
|
View |
| 27989916 |
Group 1 |
|
View |
| 25183452 |
MIE-RP |
|
View |
| 25183452 |
Robot-assisted |
|
View |
| 24582327 |
Total |
|
View |
| 24582327 |
RALP |
|
View |
| 24582327 |
RRP |
|
View |
| 24255757 |
RRP |
|
View |
| 24255757 |
RALP |
|
View |
| 24053198 |
RARP |
|
View |
| 24053198 |
RRP |
|
View |
| 24044093 |
Total |
|
View |
| 34155724 |
Group 2 |
|
View |
| 27989916 |
Group 2 |
|
View |
| 24044093 |
RALP |
|
View |
| 24044093 |
RRP |
|
View |
| 23485928 |
ORP |
|
View |
| 23485928 |
RARP |
|
View |
| 23465150 |
LRP |
|
View |
| 23465150 |
RALP |
|
View |
| 23451984 |
RRP |
|
View |
| 23451984 |
RARP |
|
View |
| 23356747 |
ORP |
|
View |
| 23356747 |
RALP |
|
View |
| 32219979 |
Peripheral zone |
|
View |
| 22949997 |
RRP |
|
View |
| 22949997 |
RALP |
|
View |
| 22949997 |
RRP |
|
View |
| 22949997 |
RALP |
|
View |
| 22111001 |
RPP |
|
View |
| 22111001 |
RRP |
|
View |
| 22111001 |
RALP |
|
View |
| 22196405 |
RRP |
|
View |
| 22196405 |
RARP |
|
View |
| 22196405 |
VUAS |
|
View |
| 32219979 |
Mixed origin |
|
View |
| 22196405 |
No VUAS |
|
View |
| 20438567 |
ORP |
|
View |
| 20438567 |
RALP |
|
View |
| 16194714 |
ORP |
|
View |
| 16194714 |
LRP |
|
View |
| 16194714 |
RRP |
|
View |
| 35136291 |
Overall |
|
View |
| 35136291 |
Group A |
|
View |
| 35136291 |
Group B |
|
View |
| 35063205 |
HOSO |
|
View |
| 32219979 |
Transitional zone |
|
View |
| 35063205 |
MAG-EPA |
|
View |
| 34970758 |
Total |
|
View |
| 34970758 |
Non-nerve-sparing RARP |
|
View |
| 34970758 |
Nerve-sparing RARP with SNR |
|
View |
| 34970758 |
Nerve-sparing RARP without SNR |
|
View |
| 27613061 |
Total |
|
View |
| 34189707 |
Total |
|
View |
| 34189707 |
NSM |
|
View |
| 34189707 |
PSM |
|
View |
| 24553487 |
Conventional pT2 |
|
View |
| 32048341 |
Ophthalmic disease (+) Glaucoma (+) |
|
View |
| 24553487 |
Modified ultradissection pT2 |
|
View |
| 32167708 |
r-PRP |
|
View |
| 31489241 |
Population |
|
View |
| 31489241 |
Negative SMs |
|
View |
| 31489241 |
Focal PSM |
|
View |
| 31489241 |
Non-focal PSM |
|
View |
| 34472768 |
Normal BMI |
|
View |
| 34472768 |
Overweight |
|
View |
| 34472768 |
Obese |
|
View |
| 34472768 |
Non-obese |
|
View |
| 32048341 |
Ophthalmic disease (+) Glaucoma (-) |
|
View |
| 28352618 |
A: ≥70 yr |
|
View |
| 28352618 |
B: <70 yr |
|
View |
| 19583731 |
≥70 years |
|
View |
| 19583731 |
<70 years |
|
View |
| 32497131 |
Age < 75 years |
|
View |
| 32497131 |
Age ≥ 75 years |
|
View |
| 26648678 |
Group 1 |
|
View |
| 26648678 |
Group 2 |
|
View |
| 31287254 |
Total |
|
View |
| 30606182 |
< 25 g |
|
View |
| 32048341 |
Normal |
|
View |
| 30606182 |
25-50 g |
|
View |
| 30606182 |
51-75 g |
|
View |
| 30606182 |
> 75 g |
|
View |
| 31337353 |
All patients |
|
View |
| 31337353 |
Non-CKD |
|
View |
| 31337353 |
CKD |
|
View |
| 31337353 |
ESRD |
|
View |
| 24969055 |
Total |
|
View |
| 34104636 |
Non-NADT |
|
View |
| 34104636 |
NADT |
|
View |
| 32048341 |
Total |
|
View |
| 34104636 |
Non-NADT |
|
View |
| 34104636 |
NADT |
|
View |
| 26539008 |
RPP |
|
View |
| 26539008 |
RRP |
|
View |
| 26539008 |
MIRP |
|
View |
| 32739147 |
Total |
|
View |
| 33819496 |
Group RRP |
|
View |
| 33819496 |
Group RALP |
|
View |
| 35173071 |
overall |
|
View |
| 30979636 |
Overall |
|
View |
| 31893344 |
Total |
|
View |
| 30979636 |
3Dgroup |
|
View |
| 30979636 |
Cognitivegroup |
|
View |
| 34410984 |
PD |
|
View |
| 34410984 |
ND |
|
View |
| 34332759 |
Overall |
|
View |
| 34332759 |
AR-3D guided IFS RARP |
|
View |
| 34332759 |
mpMRI guided RARP |
|
View |
| 34131882 |
overall |
|
View |
| 34131882 |
overall |
|
View |
| 33585117 |
Overall Cohort |
|
View |
| 31704865 |
Total |
|
View |
| 33585117 |
Overall Cohort |
|
View |
| 33585117 |
SDD |
|
View |
| 33585117 |
SDD |
|
View |
| 33585117 |
Inpatient |
|
View |
| 33585117 |
Inpatient |
|
View |
| 33380323 |
RALP |
|
View |
| 33380323 |
RAPN |
|
View |
| 33248139 |
Anticoagulant group |
|
View |
| 33248139 |
Thienopyridine group |
|
View |
| 33248139 |
Aspirin group |
|
View |
| 34155724 |
Group 1 |
|
View |
| 31673831 |
Total |
|
View |
| 33248139 |
Control group |
|
View |
| 33248139 |
Anticoagulant group |
|
View |
| 33248139 |
Thienopyridine group |
|
View |
| 33248139 |
Aspirin group |
|
View |
| 33248139 |
Control group |
|
View |
| 32945234 |
Group A |
|
View |
| 32945234 |
Group B |
|
View |
| 32929627 |
Total |
|
View |
| 32929627 |
No drain |
|
View |
| 32929627 |
Drain |
|
View |
| 26936203 |
RRP |
|
View |
| 32174775 |
VA group |
|
View |
| 32174775 |
TIVA group |
|
View |
| 32164666 |
overall |
|
View |
| 32065277 |
Inpatient cohort |
|
View |
| 32065277 |
SDD cohort |
|
View |
| 23415965 |
FS Neg |
|
View |
| 23415965 |
FS Pos |
|
View |
| 31506877 |
Conventional ventilation (CV) |
|
View |
| 31506877 |
Lung protective ventilation (LPV) |
|
View |
| 31014320 |
Bilateral nerve-sparing RARP With HA/CMC |
|
View |
| 26936203 |
RARP |
|
View |
| 31014320 |
Bilateral nerve-sparing RARP Without HA/CMC |
|
View |
| 31014320 |
Unilateral nerve-sparing RARP With HA/CMC |
|
View |
| 31014320 |
Unilateral nerve-sparing RARP Without HA/CMC |
|
View |
| 30868938 |
Group H + WB |
|
View |
| 30868938 |
Group WB |
|
View |
| 30653808 |
15 mmHg |
|
View |
| 30653808 |
6 mmHg |
|
View |
| 30652509 |
Group 1 - Non-TAP |
|
View |
| 30652509 |
Group 2 - TAP |
|
View |
| 30248343 |
Total |
|
View |
| 32720178 |
All |
|
View |
| 30248343 |
Robot assisted surgery |
|
View |
| 30248343 |
Laparoscopic surgery |
|
View |
| 30248343 |
Open surgery |
|
View |
| 29953025 |
Before propensity score matching, No-mannitol group |
|
View |
| 29953025 |
Before propensity score matching, Mannitol group |
|
View |
| 29953025 |
After propensity score matching, No-mannitol group |
|
View |
| 29953025 |
After propensity score matching, Mannitol group |
|
View |
| 29925316 |
All patients |
|
View |
| 29925316 |
Propofol group |
|
View |
| 29925316 |
Sevoflurane group |
|
View |
| 32720178 |
Inguinal hernia positive |
|
View |
| 29415565 |
Total |
|
View |
| 34789219 |
Total |
|
View |
| 29188199 |
25-degree Trendelenburg position
|
|
View |
| 29188199 |
30-degree Trendelenburg position |
|
View |
| 20840532 |
patient one |
|
View |
| 20840532 |
patient two |
|
View |
| 27758147 |
Group 1 |
|
View |
| 27758147 |
Group 2 |
|
View |
| 29177945 |
Total |
|
View |
| 27225958 |
Retropubic radical prostatectomy |
|
View |
| 32720178 |
nguinal hernia negative |
|
View |
| 27225958 |
Robotic-assisted laparoscopic prostatectomy |
|
View |
| 27225958 |
Low PEEP (0-1) |
|
View |
| 27225958 |
High PEEP (4-5) |
|
View |
| 27225958 |
Low PEEP (0-1) |
|
View |
| 27225958 |
High PEEP (4-5) |
|
View |
| 26531205 |
SD group |
|
View |
| 26531205 |
TD group |
|
View |
| 25906167 |
VF defect (-) |
|
View |
| 25906167 |
VF defect (+) |
|
View |
| 25906167 |
Total |
|
View |
| 31538242 |
Continent |
|
View |
| 34748059 |
Intratumoral |
|
View |
| 34748059 |
Intraprostatic |
|
View |
| 25129475 |
TIVA-TCI |
|
View |
| 25129475 |
BAL |
|
View |
| 25129475 |
TIVA-TCI LRP |
|
View |
| 25129475 |
TIVA-TCI RALP |
|
View |
| 25129475 |
BAL LRP |
|
View |
| 25129475 |
BAL RALP |
|
View |
| 24089234 |
Group 1 |
|
View |
| 24089234 |
Group 2 |
|
View |
| 31538242 |
Incontinent |
|
View |
| 22966792 |
Total |
|
View |
| 21902975 |
group 1 |
|
View |
| 21902975 |
group 2 |
|
View |
| 28872774 |
Arm I, ND |
|
View |
| 28872774 |
Arm II, PD |
|
View |
| 24440236 |
UC |
|
View |
| 24440236 |
SPT |
|
View |
| 22177263 |
Total |
|
View |
| 35475154 |
Overall |
|
View |
| 35475154 |
Optimal difficulty |
|
View |
| 27124625 |
2005-2008 |
|
View |
| 35475154 |
Suboptimal difficulty |
|
View |
| 35474722 |
All patients |
|
View |
| 35474722 |
Patients with PUL < 16 mm |
|
View |
| 35474722 |
Patients with PUL ≥ 16 mm |
|
View |
| 35116647 |
ALL |
|
View |
| 35116647 |
LCM |
|
View |
| 35116647 |
No LCM |
|
View |
| 34430418 |
ALL |
|
View |
| 34401332 |
Total |
|
View |
| 34401332 |
Group A |
|
View |
| 27124625 |
2009-2010 |
|
View |
| 34401332 |
Group B |
|
View |
| 34387037 |
Total |
|
View |
| 34387037 |
RARP |
|
View |
| 34387037 |
RT |
|
View |
| 34337474 |
RS-RARP |
|
View |
| 34337474 |
S-RARP |
|
View |
| 34279470 |
SCE (−) |
|
View |
| 34279470 |
SCE (+) |
|
View |
| 34186136 |
S-RALP |
|
View |
| 34186136 |
pRALP |
|
View |
| 34155724 |
Group 2 |
|
View |
| 27124625 |
2011-2012 |
|
View |
| 34168526 |
Pneumoperitoneum pressure 12 mm Hg |
|
View |
| 34168526 |
Pneumoperitoneum pressure 15 mm Hg |
|
View |
| 34135173 |
SP group |
|
View |
| 34135173 |
MP group |
|
View |
| 35929873 |
13-15mmHg |
|
View |
| 35929873 |
6mmHg |
|
View |
| 33917705 |
total |
|
View |
| 33672650 |
NLR < 2.0 |
|
View |
| 33672650 |
NLR ≥ 2.0
|
|
View |
| 33672650 |
PLR < 118 |
|
View |
| 27124625 |
2013-2015 |
|
View |
| 33672650 |
PLR ≥ 118
|
|
View |
| 33672650 |
LMR < 5.0
|
|
View |
| 33672650 |
LMR ≥ 5.0 |
|
View |
| 33672650 |
0 |
|
View |
| 33672650 |
1 |
|
View |
| 33672650 |
2 |
|
View |
| 33672650 |
3 |
|
View |
| 33644166 |
BCR group |
|
View |
| 33644166 |
Non-BCR group |
|
View |
| 33574414 |
total |
|
View |
| 27124625 |
Total |
|
View |
| 33569279 |
Experimental group |
|
View |
| 33569279 |
Control group |
|
View |
| 33396327 |
Open RP |
|
View |
| 33396327 |
Laparoscopic RP |
|
View |
| 33396327 |
Robotic RP |
|
View |
| 33289056 |
total |
|
View |
| 33057938 |
Without suspension |
|
View |
| 33057938 |
With suspension |
|
View |
| 33008371 |
hernia group |
|
View |
| 33008371 |
no-hernia group |
|
View |
| 31148505 |
Total |
|
View |
| 33008371 |
total |
|
View |
| 32738549 |
RRP |
|
View |
| 32738549 |
RARP |
|
View |
| 32674608 |
Group 1 |
|
View |
| 32674608 |
Group 2 |
|
View |
| 32602024 |
Same day |
|
View |
| 32602024 |
1-2 days |
|
View |
| 32551332 |
No Transfusion |
|
View |
| 32551332 |
Transfusion |
|
View |
| 35474865 |
NRS < 5 |
|
View |
| 31119473 |
Anterior approach |
|
View |
| 35474865 |
NRS ≥ 5 |
|
View |
| 32055475 |
caVUS |
|
View |
| 32055475 |
Non-caVUS |
|
View |
| 32015914 |
total |
|
View |
| 35475154 |
Overall |
|
View |
| 35475154 |
Optimal difficulty |
|
View |
| 35475154 |
Suboptimal difficulty |
|
View |
| 35474722 |
All patients |
|
View |
| 35474722 |
Patients with PUL < 16 mm |
|
View |
| 35474722 |
Patients with PUL ≥ 16 mm |
|
View |
| 31119473 |
Posterior approach |
|
View |
| 35116647 |
ALL |
|
View |
| 35116647 |
LCM |
|
View |
| 35116647 |
No LCM |
|
View |
| 34430418 |
ALL |
|
View |
| 34401332 |
Total |
|
View |
| 34401332 |
Group A |
|
View |
| 34401332 |
Group B |
|
View |
| 34387037 |
Total |
|
View |
| 34387037 |
RARP |
|
View |
| 34387037 |
RT |
|
View |
| 32807046 |
Total |
|
View |
| 25484948 |
Age < 50 |
|
View |
| 25484948 |
Age 50-59 |
|
View |
| 25484948 |
Age ≥ 60 |
|
View |
| 25484950 |
Bipolar |
|
View |
| 25484950 |
Athermal clip and peel |
|
View |
| 25484950 |
Athermal anterior/posterior |
|
View |
| 25484965 |
No Leakage |
|
View |
| 25484965 |
Leakage |
|
View |
| 17651548 |
Overall |
|
View |
| 17651548 |
First 70 |
|
View |
| 32807046 |
Novice |
|
View |
| 17651548 |
Second 70 |
|
View |
| 17893904 |
Overall |
|
View |
| 25484981 |
Normal |
|
View |
| 25484981 |
Overweight |
|
View |
| 25484981 |
Mildly obese |
|
View |
| 25484981 |
Severely obese |
|
View |
| 18246641 |
Normal |
|
View |
| 18246641 |
Overweight |
|
View |
| 18246641 |
Obese |
|
View |
| 20708781 |
<50 |
|
View |
| 32807046 |
Experienced |
|
View |
| 20708781 |
50-100 |
|
View |
| 20708781 |
>100 |
|
View |
| 21165525 |
total |
|
View |
| 26579289 |
Overall |
|
View |
| 26579289 |
⩽50 |
|
View |
| 26579289 |
50-80 |
|
View |
| 26579289 |
>80 |
|
View |
| 21902974 |
total |
|
View |
| 23000849 |
total |
|
View |
| 23318071 |
Negative Margin |
|
View |
| 32807046 |
Console experienced |
|
View |
| 23318071 |
Positive Margin |
|
View |
| 23318071 |
All Patients |
|
View |
| 24917775 |
Group 1 |
|
View |
| 24917775 |
Group 2 |
|
View |
| 24917775 |
Group 3 |
|
View |
| 26328083 |
Negative |
|
View |
| 26328083 |
Positive |
|
View |
| 24454607 |
ORP (Open) |
|
View |
| 24454607 |
RALRP (Robotic) |
|
View |
| 25032194 |
Group 1 TURP=yes |
|
View |
| 34120255 |
Patients with complications |
|
View |
| 31001870 |
Total |
|
View |
| 25032194 |
Group 2 TURP=no |
|
View |
| 25927060 |
RARP |
|
View |
| 25927060 |
LRP |
|
View |
| 26416058 |
all |
|
View |
| 27347619 |
Robotic |
|
View |
| 27347619 |
Open |
|
View |
| 27622285 |
Prior surgery |
|
View |
| 27622285 |
No prior surgery |
|
View |
| 28488986 |
Continued smoking |
|
View |
| 28488986 |
Quit smoking |
|
View |
| 30972506 |
All patients |
|
View |
| 28743170 |
total |
|
View |
| 36118377 |
total |
|
View |
| 36118377 |
EPE |
|
View |
| 36118377 |
No EPE |
|
View |
| 29128577 |
Overall |
|
View |
| 29128577 |
No BCR |
|
View |
| 29128577 |
BCR |
|
View |
| 29440957 |
Age> 65 years (Group 1) |
|
View |
| 29440957 |
Age < 50 years (Group 2) |
|
View |
| 29991233 |
all |
|
View |
| 30972506 |
Low - D’Amico risk classifcation |
|
View |
| 30182076 |
total |
|
View |
| 30325603 |
with BCR |
|
View |
| 30325603 |
without BCR |
|
View |
| 30332593 |
total |
|
View |
| 30521164 |
Group 1 |
|
View |
| 30521164 |
Group 2 |
|
View |
| 30978167 |
r-PRP |
|
View |
| 30978167 |
RARP |
|
View |
| 31450657 |
Higher Group |
|
View |
| 31450657 |
Lower Group |
|
View |
| 30972506 |
Intermediate - D’Amico risk classifcation |
|
View |
| 31808399 |
Group 1 |
|
View |
| 31808399 |
Group 2 |
|
View |
| 31922483 |
VTE |
|
View |
| 31922483 |
Control |
|
View |
| 34313905 |
Total cohort |
|
View |
| 34313905 |
Patients with PSM |
|
View |
| 30972506 |
High - D’Amico risk classifcation |
|
View |
| 30953271 |
Total |
|
View |
| 30953271 |
Surgical margins Negative |
|
View |
| 30953271 |
Surgical margins Positive |
|
View |
| 30929223 |
|
|
View |
| 30929223 |
|
|
View |